AtriCure, Inc.
US ˙ NasdaqGM ˙ US04963C2098

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Irwin Federman. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Irwin Federman har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:ONTF / ON24, Inc. Director 78.435
US:NARI / Inari Medical, Inc. 10% Owner 40.883
US:MLNX / Mellanox Technologies, Ltd. Director 0
US:IMI / Intermolecular, Inc. 10% Owner 0
US:INSP / Inspire Medical Systems, Inc. 10% Owner 18.212
US:BOX / Box, Inc. 10% Owner 3.713.775
US:80004CAD3 / SanDisk Corporation Bond Director 0
US:XENT / Intersect ENT Inc 10% Owner 1.995.433
US:CSLT / Castlight Health Inc - Class B 10% Owner 0
US:OMED / OptMed Inc 10% Owner 56.528
US:GWRE / Guidewire Software, Inc. 10% Owner 36.638
US:MXL / MaxLinear, Inc. 10% Owner 10.969
US:ATRC / AtriCure, Inc. 10% Owner 11.873
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Irwin Federman. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb ATRC / AtriCure, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATRC / AtriCure, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ATRC / AtriCure, Inc. Insider Trades
Insidersalg ATRC / AtriCure, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATRC / AtriCure, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2012-06-07 ATRC PRESIDIO MANAGEMENT GROUP VIII L L C 3.279 9,4440 3.279 9,4440 30.967 147 5.91 -11.587 -37,42
2012-06-07 ATRC PRESIDIO MANAGEMENT GROUP VIII L L C 1.759 9,4440 1.759 9,4440 16.612

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ATRC / AtriCure, Inc. Insider Trades
Insiderkøb BOX / Box, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATRC / AtriCure, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BOX / Box, Inc. Insider Trades
Insidersalg BOX / Box, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATRC / AtriCure, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BOX / Box, Inc. Insider Trades
Insiderkøb INSP / Inspire Medical Systems, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATRC / AtriCure, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INSP / Inspire Medical Systems, Inc. Insider Trades
Insidersalg INSP / Inspire Medical Systems, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATRC / AtriCure, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INSP / Inspire Medical Systems, Inc. Insider Trades
Insiderkøb MXL / MaxLinear, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATRC / AtriCure, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MXL / MaxLinear, Inc. Insider Trades
Insidersalg MXL / MaxLinear, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATRC / AtriCure, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2012-08-21 MXL PRESIDIO MANAGEMENT GROUP VIII L L C 488.481 5,5900 488.481 5,5900 2.730.609 365 7.8500 1.103.968 40,43
2012-08-21 MXL PRESIDIO MANAGEMENT GROUP VIII L L C 4.715 5,5900 4.715 5,5900 26.357
2012-08-21 MXL PRESIDIO MANAGEMENT GROUP VIII L L C 4.515 5,5900 4.515 5,5900 25.239
2012-08-21 MXL PRESIDIO MANAGEMENT GROUP VIII L L C 2.289 5,5900 2.289 5,5900 12.796
2012-05-30 MXL PRESIDIO MANAGEMENT GROUP VIII L L C 3.235 4,2020 3.235 4,2020 13.593
2012-05-30 MXL PRESIDIO MANAGEMENT GROUP VIII L L C 1.640 4,2020 1.640 4,2020 6.891

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MXL / MaxLinear, Inc. Insider Trades
Insiderkøb ONTF / ON24, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATRC / AtriCure, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ONTF / ON24, Inc. Insider Trades
Insidersalg ONTF / ON24, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATRC / AtriCure, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2021-08-31 ONTF FEDERMAN IRWIN 597 22,5500 597 22,5500 13.462 364 8.8900 -8.155 -60,58
2021-08-31 ONTF FEDERMAN IRWIN 29.880 22,5500 29.880 22,5500 673.794
2021-08-31 ONTF FEDERMAN IRWIN 29.880 22,5500 29.880 22,5500 673.794
2021-08-24 ONTF FEDERMAN IRWIN 312 22,1300 312 22,1300 6.905
2021-08-24 ONTF FEDERMAN IRWIN 15.625 22,1300 15.625 22,1300 345.781
2021-08-24 ONTF FEDERMAN IRWIN 15.625 22,1300 15.625 22,1300 345.781
2021-08-18 ONTF FEDERMAN IRWIN 312 20,0300 312 20,0300 6.249
2021-08-12 ONTF FEDERMAN IRWIN 15.625 21,2000 15.625 21,2000 331.250
2021-08-12 ONTF FEDERMAN IRWIN 15.625 21,2000 15.625 21,2000 331.250
2021-08-11 ONTF FEDERMAN IRWIN 312 21,2000 312 21,2000 6.614

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ONTF / ON24, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Irwin Federman som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2024-06-25 2024-06-21 4 ONTF ON24 INC.
Common Stock
A - Award 30.198 78.435 62,60
2023-06-27 2023-06-23 4 ONTF ON24 INC.
Common Stock
A - Award 21.547 48.237 80,73
2022-06-13 2022-06-10 4 ONTF ON24 INC.
Common Stock
A - Award 14.586 24.376 148,99
2021-09-01 2021-08-31 4 ONTF ON24 INC.
Common Stock
S - Sale -29.880 0 -100,00 22,55 -673.794
2021-09-01 2021-08-31 4 ONTF ON24 INC.
Common Stock
S - Sale -29.880 0 -100,00 22,55 -673.794
2021-09-01 2021-08-31 4 ONTF ON24 INC.
Common Stock
S - Sale -597 0 -100,00 22,55 -13.462
2021-09-01 2021-08-30 4 ONTF ON24 INC.
Common Stock
J - Other 3.811 9.790 63,74
2021-09-01 2021-08-30 4 ONTF ON24 INC.
Common Stock
J - Other 597 597
2021-09-01 2021-08-30 4 ONTF ON24 INC.
Common Stock
J - Other -59.758 0 -100,00
2021-09-01 2021-08-30 4 ONTF ON24 INC.
Common Stock
J - Other -2.868.405 0 -100,00
2021-08-25 2021-08-24 4 ONTF ON24 INC.
Common Stock
S - Sale -15.625 29.880 -34,34 22,13 -345.781 661.244
2021-08-25 2021-08-24 4 ONTF ON24 INC.
Common Stock
S - Sale -15.625 29.880 -34,34 22,13 -345.781 661.244
2021-08-25 2021-08-24 4 ONTF ON24 INC.
Common Stock
S - Sale -312 0 -100,00 22,13 -6.905
2021-08-25 2021-08-23 4 ONTF ON24 INC.
Common Stock
J - Other 1.993 5.979 50,00
2021-08-25 2021-08-23 4 ONTF ON24 INC.
Common Stock
J - Other 312 312
2021-08-25 2021-08-23 4 ONTF ON24 INC.
Common Stock
J - Other -31.250 59.758 -34,34
2021-08-25 2021-08-23 4 ONTF ON24 INC.
Common Stock
J - Other -1.500.000 2.868.405 -34,34
2021-08-19 2021-08-18 4 ONTF ON24 INC.
Common Stock
S - Sale -15.625 45.505 -25,56 20,03 -312.969 911.465
2021-08-19 2021-08-18 4 ONTF ON24 INC.
Common Stock
S - Sale -15.625 45.505 -25,56 20,03 -312.969 911.465
2021-08-19 2021-08-18 4 ONTF ON24 INC.
Common Stock
S - Sale -312 0 -100,00 20,03 -6.249
2021-08-19 2021-08-17 4 ONTF ON24 INC.
Common Stock
J - Other 1.993 3.986 100,00
2021-08-19 2021-08-17 4 ONTF ON24 INC.
Common Stock
J - Other 312 312
2021-08-19 2021-08-17 4 ONTF ON24 INC.
Common Stock
J - Other -31.250 91.008 -25,56
2021-08-19 2021-08-17 4 ONTF ON24 INC.
Common Stock
J - Other -1.500.000 4.368.405 -25,56
2021-08-13 2021-08-12 4 ONTF ON24 INC.
Common Stock
S - Sale -15.625 61.130 -20,36 21,20 -331.250 1.295.956
2021-08-13 2021-08-12 4 ONTF ON24 INC.
Common Stock
S - Sale -15.625 61.130 -20,36 21,20 -331.250 1.295.956
2021-08-13 2021-08-11 4 ONTF ON24 INC.
Common Stock
S - Sale -312 0 -100,00 21,20 -6.614
2021-08-13 2021-08-11 4 ONTF ON24 INC.
Common Stock
J - Other 1.993 1.993
2021-08-13 2021-08-11 4 ONTF ON24 INC.
Common Stock
J - Other 312 312
2021-08-13 2021-08-11 4 ONTF ON24 INC.
Common Stock
J - Other -31.250 122.258 -20,36
2021-08-13 2021-08-11 4 ONTF ON24 INC.
Common Stock
J - Other -1.500.000 5.868.405 -20,36
2021-02-05 2021-02-05 4 ONTF ON24 INC.
Class A-2 Preferred Stock
C - Conversion -53.404 0 -100,00
2021-02-05 2021-02-05 4 ONTF ON24 INC.
Class A-2 Preferred Stock
C - Conversion -53.404 0 -100,00
2021-02-05 2021-02-05 4 ONTF ON24 INC.
Class A-2 Preferred Stock
C - Conversion -5.126.735 0 -100,00
2021-02-05 2021-02-05 4 ONTF ON24 INC.
Class A-2 Preferred Stock
C - Conversion -106.807 0 -100,00
2021-02-05 2021-02-05 4 ONTF ON24 INC.
Class A-1 Preferred Stock
C - Conversion -23.351 0 -100,00
2021-02-05 2021-02-05 4 ONTF ON24 INC.
Class A-1 Preferred Stock
C - Conversion -23.351 0 -100,00
2021-02-05 2021-02-05 4 ONTF ON24 INC.
Class A-1 Preferred Stock
C - Conversion -2.241.670 0 -100,00
2021-02-05 2021-02-05 4 ONTF ON24 INC.
Class A-1 Preferred Stock
C - Conversion -46.701 0 -100,00
2021-02-05 2021-02-05 4 ONTF ON24 INC.
Common Stock
C - Conversion 76.755 76.755
2021-02-05 2021-02-05 4 ONTF ON24 INC.
Common Stock
C - Conversion 76.755 76.755
2021-02-05 2021-02-05 4 ONTF ON24 INC.
Common Stock
C - Conversion 7.368.405 7.368.405
2021-02-05 2021-02-05 4 ONTF ON24 INC.
Common Stock
C - Conversion 153.508 153.508
2020-11-19 2020-11-18 4 NARI Inari Medical, Inc.
Common Stock
S - Sale -20.000 40.883 -32,85 66,38 -1.327.600 2.713.814
2020-11-19 2020-11-17 4 NARI Inari Medical, Inc.
Common Stock
J - Other 34.576 34.576
2020-11-19 2020-11-17 4 NARI Inari Medical, Inc.
Common Stock
J - Other 34.576 34.576
2020-11-19 2020-11-17 4 NARI Inari Medical, Inc.
Common Stock
J - Other 11.794 11.794
2020-11-19 2020-11-17 4 NARI Inari Medical, Inc.
Common Stock
J - Other 67.730 67.730
2020-11-19 2020-11-17 4 NARI Inari Medical, Inc.
Common Stock
J - Other 56.173 56.173
2020-11-19 2020-11-17 4 NARI Inari Medical, Inc.
Common Stock
J - Other 60.883 60.883
2020-11-19 2020-11-17 4 NARI Inari Medical, Inc.
Common Stock
J - Other 37.268 37.268
2020-11-19 2020-11-17 4 NARI Inari Medical, Inc.
Common Stock
J - Other -587.851 0 -100,00
2020-11-19 2020-11-17 4 NARI Inari Medical, Inc.
Common Stock
J - Other 587.851 587.851
2020-11-19 2020-11-17 4 NARI Inari Medical, Inc.
Common Stock
J - Other -71.840 167.627 -30,00
2020-11-19 2020-11-17 4 NARI Inari Medical, Inc.
Common Stock
J - Other -2.245.605 5.239.744 -30,00
2020-05-27 2020-05-27 4 NARI Inari Medical, Inc.
Series C Preferred Stock
C - Conversion -72.887 0 -100,00
2020-05-27 2020-05-27 4 NARI Inari Medical, Inc.
Series C Preferred Stock
C - Conversion -2.278.331 0 -100,00
2020-05-27 2020-05-27 4 NARI Inari Medical, Inc.
Series B Preferred Stock
C - Conversion -92.771 0 -100,00
2020-05-27 2020-05-27 4 NARI Inari Medical, Inc.
Series B Preferred Stock
C - Conversion -2.899.876 0 -100,00
2020-05-27 2020-05-27 4 NARI Inari Medical, Inc.
Series A Preferred Stock
C - Conversion -73.809 0 -100,00
2020-05-27 2020-05-27 4 NARI Inari Medical, Inc.
Series A Preferred Stock
C - Conversion -2.307.142 0 -100,00
2020-05-27 2020-05-27 4 NARI Inari Medical, Inc.
Common Stock
P - Purchase 97.962 97.962 19,00 1.861.278 1.861.278
2020-05-27 2020-05-27 4 NARI Inari Medical, Inc.
Common Stock
C - Conversion 72.887 239.467 43,75
2020-05-27 2020-05-27 4 NARI Inari Medical, Inc.
Common Stock
C - Conversion 92.771 166.580 125,69
2020-05-27 2020-05-27 4 NARI Inari Medical, Inc.
Common Stock
C - Conversion 73.809 73.809
2020-05-27 2020-05-27 4 NARI Inari Medical, Inc.
Common Stock
C - Conversion 2.278.331 7.485.349 43,76
2020-05-27 2020-05-27 4 NARI Inari Medical, Inc.
Common Stock
C - Conversion 2.899.876 5.207.018 125,69
2020-05-27 2020-05-27 4 NARI Inari Medical, Inc.
Common Stock
C - Conversion 2.307.142 2.307.142
2020-04-27 2020-04-27 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
D - Sale to Issuer -633 0 -100,00 125,00 -79.125
2020-04-27 2020-04-27 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
D - Sale to Issuer -45.332 633 -98,62 125,00 -5.666.500 79.125
2019-09-20 2019-09-20 4 IMI INTERMOLECULAR INC
Stock Option
U - Other -25.000 0 -100,00
2019-09-20 2019-09-20 4 IMI INTERMOLECULAR INC
Stock Option
U - Other -25.000 0 -100,00
2019-09-20 2019-09-20 4 IMI INTERMOLECULAR INC
Stock Option
U - Other -25.000 0 -100,00
2019-09-20 2019-09-20 4 IMI INTERMOLECULAR INC
Stock Option
U - Other -25.000 0 -100,00
2019-09-20 2019-09-20 4 IMI INTERMOLECULAR INC
Stock Option
U - Other -10.000 0 -100,00
2019-09-20 2019-09-20 4 IMI INTERMOLECULAR INC
Stock Option
U - Other -10.000 0 -100,00
2019-09-20 2019-09-20 4 IMI INTERMOLECULAR INC
Stock Option
U - Other -10.000 0 -100,00
2019-09-20 2019-09-20 4 IMI INTERMOLECULAR INC
Common Stock
U - Other -538.267 0 -100,00
2019-07-26 2019-07-25 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
A - Award 2.532 45.965 5,83
2018-11-13 2018-11-08 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
J - Other -4.280.779 0 -100,00
2018-11-13 2018-11-08 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
J - Other 82.370 538.267 18,07
2018-11-13 2018-11-08 4 INSP Inspire Medical Systems, Inc.
Common Stock
J - Other 18.212 18.212
2018-11-13 2018-11-08 4 INSP Inspire Medical Systems, Inc.
Common Stock
J - Other 18.212 18.212
2018-11-13 2018-11-08 4 INSP Inspire Medical Systems, Inc.
Common Stock
J - Other 18.982 18.982
2018-11-13 2018-11-08 4 INSP Inspire Medical Systems, Inc.
Common Stock
J - Other 13.356 13.356
2018-11-13 2018-11-08 4 INSP Inspire Medical Systems, Inc.
Common Stock
J - Other 15.391 15.391
2018-11-13 2018-11-08 4 INSP Inspire Medical Systems, Inc.
Common Stock
J - Other 22.573 22.573
2018-11-13 2018-11-08 4 INSP Inspire Medical Systems, Inc.
Common Stock
J - Other -216.825 0 -100,00
2018-11-13 2018-11-08 4 INSP Inspire Medical Systems, Inc.
Common Stock
J - Other 216.825 216.825
2018-11-13 2018-11-08 4 INSP Inspire Medical Systems, Inc.
Common Stock
J - Other -1.084.127 1.084.127 -50,00
2018-07-27 2018-07-25 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
A - Award 4.200 43.433 10,71
2018-05-29 2018-05-24 4 IMI INTERMOLECULAR INC
Stock Option (Right to Buy)
A - Award 25.000 25.000
2018-05-09 2018-05-07 4 INSP Inspire Medical Systems, Inc.
Series F Convertible Preferred Stock
C - Conversion -3.795.620 0 -100,00
2018-05-09 2018-05-07 4 INSP Inspire Medical Systems, Inc.
Series E Convertible Preferred Stock
C - Conversion -948.855 0 -100,00
2018-05-09 2018-05-07 4 INSP Inspire Medical Systems, Inc.
Series D Convertible Preferred Stock
C - Conversion -1.397.478 0 -100,00
2018-05-09 2018-05-07 4 INSP Inspire Medical Systems, Inc.
Series C Convertible Preferred Stock
C - Conversion -3.142.670 0 -100,00
2018-05-09 2018-05-07 4 INSP Inspire Medical Systems, Inc.
Series B Convertible Preferred Stock
C - Conversion -2.102.315 0 -100,00
2018-05-09 2018-05-07 4 INSP Inspire Medical Systems, Inc.
Series A Convertible Preferred Stock
C - Conversion -2.400.000 0 -100,00
2018-05-09 2018-05-07 4 INSP Inspire Medical Systems, Inc.
Common Stock
C - Conversion 570.769 2.168.254 35,73
2018-05-09 2018-05-07 4 INSP Inspire Medical Systems, Inc.
Common Stock
C - Conversion 163.962 1.597.485 11,44
2018-05-09 2018-05-07 4 INSP Inspire Medical Systems, Inc.
Common Stock
C - Conversion 210.147 1.433.523 17,18
2018-05-09 2018-05-07 4 INSP Inspire Medical Systems, Inc.
Common Stock
C - Conversion 472.581 1.223.376 62,94
2018-05-09 2018-05-07 4 INSP Inspire Medical Systems, Inc.
Common Stock
C - Conversion 389.893 750.795 108,03
2018-05-09 2018-05-07 4 INSP Inspire Medical Systems, Inc.
Common Stock
C - Conversion 360.902 360.902
2017-08-22 2017-08-18 4 MLNX Mellanox Technologies, Ltd.
Common Stock
G - Gift -600 39.233 -1,51
2017-06-08 2017-06-02 4/A BOX BOX INC
Class B Common Stock
C - Conversion -8.000.000 3.713.775 -68,30
2017-06-08 2017-06-02 4/A BOX BOX INC
Class A Common Stock
J - Other -8.000.000 0 -100,00
2017-06-08 2017-06-02 4/A BOX BOX INC
Class A Common Stock
C - Conversion 8.000.000 8.000.000
2017-06-05 2017-06-02 4 BOX BOX INC
Class B Common Stock
C - Conversion -8.000.000 3.713.775 -68,30
2017-06-05 2017-06-02 4 BOX BOX INC
Class A Common Stock
J - Other -8.000.000 0 -100,00
2017-06-05 2017-06-02 4 BOX BOX INC
Class A Common Stock
C - Conversion 8.000.000 8.000.000
2017-05-24 2017-05-16 4 IMI INTERMOLECULAR INC
Stock Option (right to buy)
A - Award 25.000 25.000
2017-04-27 2017-04-25 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
A - Award 4.200 39.833 11,79
2016-08-15 2016-08-15 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 79.290 455.897 21,05 1,25 99.105 569.826
2016-08-15 2016-08-12 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 20.710 376.607 5,82 1,25 25.888 470.759
2016-05-26 2016-05-25 4 IMI INTERMOLECULAR INC
Stock Option (right to buy)
A - Award 25.000 25.000
2016-05-19 2016-05-17 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 100.000 355.897 39,08 1,90 190.430 677.735
2016-05-13 2016-05-12 4 SNDK SANDISK CORP
Non-Qualified Stock Option
D - Sale to Issuer -6.250 0 -100,00
2016-05-13 2016-05-12 4 SNDK SANDISK CORP
Non-Qualified Stock Option
D - Sale to Issuer -6.250 0 -100,00
2016-05-13 2016-05-12 4 SNDK SANDISK CORP
Non-Qualified Stock Option
D - Sale to Issuer -6.250 0 -100,00
2016-05-13 2016-05-12 4 SNDK SANDISK CORP
Common Stock
D - Sale to Issuer -31.937 0 -100,00
2016-05-11 2016-05-10 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
A - Award 4.500 35.633 14,45
2016-04-27 2016-04-26 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
S - Sale -25.000 31.133 -44,54 45,54 -1.138.390 1.417.660
2016-02-26 2016-02-24 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 5.900 255.897 2,36 2,12 12.502 542.220
2016-02-17 2016-02-16 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 4.316 249.997 1,76 2,12 9.150 529.994
2016-02-17 2016-02-12 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 400 245.681 0,16 2,12 848 520.844
2016-02-12 2016-02-11 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 5.236 245.281 2,18 2,11 11.031 516.758
2016-02-12 2016-02-10 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 12.642 240.045 5,56 2,10 26.522 503.590
2015-12-09 2015-12-09 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 5.603 227.403 2,53 2,05 11.486 466.176
2015-12-09 2015-12-08 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 1.600 221.800 0,73 2,04 3.266 452.760
2015-12-09 2015-12-07 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 200 220.200 0,09 2,05 410 451.410
2015-12-07 2015-12-03 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 1.100 220.000 0,50 2,05 2.252 450.406
2015-11-19 2015-11-17 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 4.600 218.900 2,15 2,03 9.349 444.892
2015-11-17 2015-11-16 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 51.041 214.300 31,26 2,00 102.281 429.436
2015-11-17 2015-11-13 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 13.259 163.259 8,84 2,00 26.548 326.893
2015-06-22 2015-06-18 4 SNDK SANDISK CORP
Non-Qualified Stock Option (Right to Buy)
A - Award 6.250 6.250
2015-06-22 2015-06-18 4 SNDK SANDISK CORP
Common Stock
A - Award 1.927 31.937 6,42
2015-06-15 2015-05-27 4 IMI INTERMOLECULAR INC
Stock Option (right to buy)
A - Award 25.000 25.000
2015-05-13 2015-05-12 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
A - Award 4.500 56.133 8,72
2015-05-11 2015-05-08 4 XENT Intersect ENT, Inc.
Common Stock
J - Other -990.000 1.995.433 -33,16
2015-03-06 2015-03-02 4 XENT Intersect ENT, Inc.
Common Stock
J - Other -990.000 2.985.433 -24,90
2015-02-09 2014-10-21 5 SNDK SANDISK CORP
Common Stock
G - Gift -850 30.010 -2,75
2015-01-30 2015-01-28 4 BOX BOX INC
Class B Common Stock
J - Other 11.713.775 11.713.775
2015-01-30 2015-01-28 4 BOX BOX INC
Series D Preferred Stock
C - Conversion -943.672 0 -100,00
2015-01-30 2015-01-28 4 BOX BOX INC
Series C Preferred Stock
C - Conversion -2.486.922 0 -100,00
2015-01-30 2015-01-28 4 BOX BOX INC
Series B Preferred Stock
C - Conversion -8.283.181 0 -100,00
2015-01-30 2015-01-28 4 BOX BOX INC
Existing Class A Common Stock
J - Other -11.713.775 0 -100,00
2015-01-30 2015-01-28 4 BOX BOX INC
Existing Class A Common Stock
C - Conversion 11.713.775 11.713.775
2014-11-14 2014-11-13 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 50.000 150.000 50,00 2,14 107.225 321.675
2014-11-05 2014-11-04 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
P - Purchase 100.000 100.000 2,25 224.960 224.960
2014-09-10 2014-09-09 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
J - Other -37.443 0 -100,00
2014-09-10 2014-09-09 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
J - Other -1.170.392 0 -100,00
2014-09-10 2014-09-09 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
C - Conversion 37.443 37.443
2014-09-10 2014-09-09 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
C - Conversion 1.170.392 1.170.392
2014-09-10 2014-09-09 4 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
C - Conversion -37.443 37.443 -50,00
2014-09-10 2014-09-09 4 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
C - Conversion -1.170.392 1.170.392 -50,00
2014-08-12 2014-08-08 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other 27.572 56.528 95,22
2014-08-12 2014-08-08 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other 8.863 18.170 95,23
2014-08-12 2014-08-08 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other 27.573 27.573
2014-08-12 2014-08-08 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other 33.089 50.471 190,36
2014-08-12 2014-08-08 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other 27.573 27.573
2014-08-12 2014-08-08 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other -285.734 0 -100,00
2014-08-12 2014-08-08 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other 285.734 285.734
2014-08-12 2014-08-08 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other -9.046 19.215 -32,01
2014-08-12 2014-08-08 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other -937.205 1.990.783 -32,01
2014-07-30 2014-07-29 4 XENT Intersect ENT, Inc.
Series D Convertible Preferred Stock
C - Conversion -746.054 0 -100,00
2014-07-30 2014-07-29 4 XENT Intersect ENT, Inc.
Series C Convertible Preferred Stock
C - Conversion -1.292.216 0 -100,00
2014-07-30 2014-07-29 4 XENT Intersect ENT, Inc.
Series B Convertible Preferred Stock
C - Conversion -817.034 0 -100,00
2014-07-30 2014-07-29 4 XENT Intersect ENT, Inc.
Series A Convertible Preferred Stock
C - Conversion -1.120.129 0 -100,00
2014-07-30 2014-07-29 4 XENT Intersect ENT, Inc.
Common Stock
C - Conversion 746.054 3.975.433 23,10
2014-07-30 2014-07-29 4 XENT Intersect ENT, Inc.
Common Stock
C - Conversion 1.292.216 3.229.379 66,71
2014-07-30 2014-07-29 4 XENT Intersect ENT, Inc.
Common Stock
C - Conversion 817.034 1.937.163 72,94
2014-07-30 2014-07-29 4 XENT Intersect ENT, Inc.
Common Stock
C - Conversion 1.120.129 1.120.129
2014-06-23 2014-06-19 4 SNDK SANDISK CORP
Non-Qualified Stock Option (Right to Buy)
A - Award 6.250 6.250
2014-06-23 2014-06-19 4 SNDK SANDISK CORP
Common Stock
A - Award 1.230 30.860 4,15
2014-06-02 2014-05-28 4 IMI INTERMOLECULAR INC
Stock Option (right to buy)
A - Award 10.000 10.000
2014-05-20 2014-05-20 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
A - Award 5.000 51.633 10,72
2014-05-19 2014-05-15 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
S - Sale -28.956 0 -100,00 22,51 -651.800
2014-05-13 2014-05-12 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
S - Sale -28.956 0 -100,00 21,99 -636.742
2014-05-13 2014-05-12 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
S - Sale -17.371 17.382 -49,98 21,98 -381.815 382.056
2014-05-13 2014-05-09 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other 28.956 28.956
2014-05-13 2014-05-09 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other 28.956 28.956
2014-05-13 2014-05-09 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other 9.307 9.307
2014-05-13 2014-05-09 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other 34.743 34.743
2014-05-13 2014-05-09 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other 28.966 28.966
2014-05-13 2014-05-09 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other -300.063 0 -100,00
2014-05-13 2014-05-09 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other 300.063 300.063
2014-05-13 2014-05-09 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other -9.421 28.261 -25,00
2014-05-13 2014-05-09 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
J - Other -975.996 2.927.988 -25,00
2014-05-12 2014-05-12 4 SNDK SANDISK CORP
Common Stock
S - Sale -15.000 29.630 -33,61 90,63 -1.359.508 2.685.482
2014-03-20 2014-03-19 4 CSLT CASTLIGHT HEALTH, INC.
Series D Preferred Stock
C - Conversion -15.668 0 -100,00
2014-03-20 2014-03-19 4 CSLT CASTLIGHT HEALTH, INC.
Series C Preferred Stock
C - Conversion -52.784 0 -100,00
2014-03-20 2014-03-19 4 CSLT CASTLIGHT HEALTH, INC.
Series A1 Preferred Stock
C - Conversion -1.639 0 -100,00
2014-03-20 2014-03-19 4 CSLT CASTLIGHT HEALTH, INC.
Series A Preferred Stock
C - Conversion -4.170 0 -100,00
2014-03-20 2014-03-19 4 CSLT CASTLIGHT HEALTH, INC.
Series D Preferred Stock
C - Conversion -489.752 0 -100,00
2014-03-20 2014-03-19 4 CSLT CASTLIGHT HEALTH, INC.
Series C Preferred Stock
C - Conversion -1.649.919 0 -100,00
2014-03-20 2014-03-19 4 CSLT CASTLIGHT HEALTH, INC.
Series A1 Preferred Stock
C - Conversion -51.223 0 -100,00
2014-03-20 2014-03-19 4 CSLT CASTLIGHT HEALTH, INC.
Series A Preferred Stock
C - Conversion -130.339 0 -100,00
2014-03-20 2014-03-19 4 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
C - Conversion 74.261 74.886 11.881,76
2014-03-20 2014-03-19 4 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
C - Conversion 2.321.233 2.340.784 11.872,71
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
39.727
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
20.801
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
39.727
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
20.801
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
39.727
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
20.801
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
39.727
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
20.801
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
39.727
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
20.801
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
39.727
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
20.801
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
39.727
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
20.801
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
39.727
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
20.801
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
39.727
2014-03-13 3 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
20.801
2014-02-10 2014-02-06 4 SNDK SANDISK CORP
Non-Qualified Stock Option
M - Exercise -6.250 0 -100,00
2014-02-10 2014-02-06 4 SNDK SANDISK CORP
Non-Qualified Stock Option
M - Exercise -6.250 0 -100,00
2014-02-10 2014-02-06 4 SNDK SANDISK CORP
Non-Qualified Stock Option
M - Exercise -6.250 0 -100,00
2014-02-10 2014-02-06 4 SNDK SANDISK CORP
Non-Qualified Stock Option
M - Exercise -6.250 0 -100,00
2014-02-10 2014-02-06 4 SNDK SANDISK CORP
Common Stock
S - Sale -25.000 44.630 -35,90 69,70 -1.742.570 3.110.836
2014-02-10 2014-02-06 4 SNDK SANDISK CORP
Common Stock
M - Exercise 6.250 69.630 9,86 43,05 269.062 2.997.572
2014-02-10 2014-02-06 4 SNDK SANDISK CORP
Common Stock
M - Exercise 6.250 63.380 10,94 35,95 224.688 2.278.511
2014-02-10 2014-02-06 4 SNDK SANDISK CORP
Common Stock
M - Exercise 6.250 57.130 12,28 46,43 290.188 2.652.546
2014-02-10 2014-02-06 4 SNDK SANDISK CORP
Common Stock
M - Exercise 6.250 50.880 14,00 42,00 262.500 2.136.960
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Series B-1 Preferred Stock
C - Conversion -14.527 0 -100,00
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Series B-1 Preferred Stock
C - Conversion -7.051 0 -100,00
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Series B-1 Preferred Stock
C - Conversion -13.910 0 -100,00
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Series B-1 Preferred Stock
C - Conversion -1.505.032 0 -100,00
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Series B Preferred Stock
C - Conversion -11.731 0 -100,00
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Series B Preferred Stock
C - Conversion -5.694 0 -100,00
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Series B Preferred Stock
C - Conversion -11.233 0 -100,00
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Series B Preferred Stock
C - Conversion -1.215.407 0 -100,00
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Series A Preferred Stock
C - Conversion -9.926 0 -100,00
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Series A Preferred Stock
C - Conversion -4.817 0 -100,00
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Series A Preferred Stock
C - Conversion -9.505 0 -100,00
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Series A Preferred Stock
C - Conversion -1.028.381 0 -100,00
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
P - Purchase 1.498 37.682 4,14 17,00 25.466 640.594
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
C - Conversion 14.527 36.184 67,08
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
C - Conversion 11.731 21.657 118,18
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
C - Conversion 9.926 9.926
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
P - Purchase 727 18.289 4,14 17,00 12.359 310.913
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
C - Conversion 7.051 17.562 67,08
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
C - Conversion 5.694 10.511 118,21
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
C - Conversion 4.817 4.817
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
P - Purchase 1.434 36.082 4,14 17,00 24.378 613.394
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
C - Conversion 13.910 34.648 67,07
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
C - Conversion 11.233 20.738 118,18
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
C - Conversion 9.505 9.505
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
P - Purchase 155.164 3.903.984 4,14 17,00 2.637.788 66.367.728
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
C - Conversion 1.505.032 3.748.820 67,08
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
C - Conversion 1.215.407 2.243.788 118,19
2013-07-23 2013-07-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
C - Conversion 1.028.381 1.028.381
2013-06-14 2013-06-12 4 SNDK SANDISK CORP
Non-Qualified Stock Option (Right to Buy)
A - Award 6.250 6.250
2013-06-14 2013-06-12 4 SNDK SANDISK CORP
Common Stock
A - Award 1.356 44.630 3,13
2013-06-04 2013-06-04 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
A - Award 5.000 46.633 12,01
2013-05-29 2013-05-29 4 IMI INTERMOLECULAR INC
Stock Option (right to buy)
A - Award 10.000 10.000
2013-01-23 2012-12-24 5 SNDK SANDISK CORP
Common Stock
G - Gift -8.644 43.274 -16,65
2013-01-23 2012-09-05 5 SNDK SANDISK CORP
Common Stock
G - Gift -35.000 51.918 -40,27
2012-09-25 2012-09-25 4 GWRE Guidewire Software, Inc.
Common Stock
J - Other -14.737 36.638 -28,69
2012-09-25 2012-09-25 4 GWRE Guidewire Software, Inc.
Common Stock
J - Other -2.000.000 4.972.862 -28,68
2012-09-18 2012-09-18 4 GWRE Guidewire Software, Inc.
Common Stock
S - Sale -1.669 35.047 -4,55 31,13 -51.955 1.091.003
2012-09-18 2012-09-18 4 GWRE Guidewire Software, Inc.
Common Stock
S - Sale -3.111 65.325 -4,55 31,13 -96.844 2.033.548
2012-09-18 2012-09-17 4 GWRE Guidewire Software, Inc.
Common Stock
S - Sale -7.127 36.716 -16,26 31,30 -223.091 1.149.295
2012-09-18 2012-09-17 4 GWRE Guidewire Software, Inc.
Common Stock
S - Sale -13.284 68.436 -16,26 31,30 -415.820 2.142.204
2012-09-12 2012-09-10 4 GWRE Guidewire Software, Inc.
Common Stock
J - Other -12.895 51.375 -20,06
2012-09-12 2012-09-10 4 GWRE Guidewire Software, Inc.
Common Stock
J - Other -1.750.000 6.972.862 -20,06
2012-08-22 2012-08-21 4 MXL MAXLINEAR INC
Class B Common Stock (convertible into Class A Common Stock)
S - Sale -2.289 10.969 -17,27 5,59 -12.796 61.317
2012-08-22 2012-08-21 4 MXL MAXLINEAR INC
Class B Common Stock (convertible into Class A Common Stock)
S - Sale -4.515 21.639 -17,26 5,59 -25.239 120.962
2012-08-22 2012-08-21 4 MXL MAXLINEAR INC
Class B Common Stock (convertible into Class A Common Stock)
S - Sale -4.715 22.599 -17,26 5,59 -26.357 126.328
2012-08-22 2012-08-21 4 MXL MAXLINEAR INC
Class B Common Stock (convertible into Class A Common Stock)
S - Sale -488.481 2.341.364 -17,26 5,59 -2.730.609 13.088.225
2012-07-30 2012-07-26 4 MLNX Mellanox Technologies, Ltd.
Stock Option (Right to Buy)
M - Exercise -11.428 0 -100,00
2012-07-30 2012-07-26 4 MLNX Mellanox Technologies, Ltd.
Stock Option (Right to Buy)
M - Exercise -11.428 0 -100,00
2012-07-30 2012-07-26 4 MLNX Mellanox Technologies, Ltd.
Stock Option (Right to Buy)
M - Exercise -11.428 0 -100,00
2012-07-30 2012-07-26 4 MLNX Mellanox Technologies, Ltd.
Stock Option (Right to Buy)
M - Exercise -4.142 0 -100,00
2012-07-30 2012-07-26 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
S - Sale -11.428 41.633 -21,54 99,16 -1.133.216 4.128.387
2012-07-30 2012-07-26 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
M - Exercise 11.428 53.061 27,45 11,74 134.165 622.936
2012-07-30 2012-07-26 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
S - Sale -11.428 41.633 -21,54 99,81 -1.140.585 4.155.232
2012-07-30 2012-07-26 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
M - Exercise 11.428 53.061 27,45 15,56 177.820 825.629
2012-07-30 2012-07-26 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
S - Sale -11.428 41.633 -21,54 100,13 -1.144.271 4.168.658
2012-07-30 2012-07-26 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
M - Exercise 11.428 53.061 27,45 18,43 210.618 977.914
2012-07-30 2012-07-26 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
S - Sale -4.142 41.633 -9,05 100,57 -416.573 4.187.156
2012-07-30 2012-07-26 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
M - Exercise 4.142 45.775 9,95 6,65 27.544 304.404
2012-06-15 2012-06-14 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
S - Sale -1.209 4.280.779 -0,03 6,70 -8.100 28.681.219
2012-06-14 2012-06-13 4 ATRC AtriCure, Inc.
Common Stock
J - Other -2.579 11.873 -17,85
2012-06-14 2012-06-13 4 ATRC AtriCure, Inc.
Common Stock
J - Other -350.000 1.502.444 -18,89
2012-06-13 2012-06-13 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
S - Sale -15.263 4.281.988 -0,36 6,80 -103.773 29.113.236
2012-06-13 2012-06-12 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
S - Sale -53.368 4.297.251 -1,23 6,78 -361.995 29.148.254
2012-06-13 2012-06-11 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
S - Sale -150.000 4.350.619 -3,33 6,75 -1.012.500 29.366.678
2012-06-13 2012-06-12 4 SNDK SANDISK CORP
Non-Qualified Stock Option (Right to Buy)
A - Award 6.250 6.250
2012-06-13 2012-06-12 4 SNDK SANDISK CORP
Common Stock
A - Award 2.269 86.918 2,68
2012-06-07 2012-06-07 4 ATRC AtriCure, Inc.
Common Stock
S - Sale -1.759 9.858 -15,14 9,44 -16.612 93.099
2012-06-07 2012-06-07 4 ATRC AtriCure, Inc.
Common Stock
S - Sale -3.279 18.374 -15,14 9,44 -30.967 173.524
2012-06-07 2012-06-06 4 ATRC AtriCure, Inc.
Common Stock
J - Other -2.579 14.452 -15,14
2012-06-07 2012-06-06 4 ATRC AtriCure, Inc.
Common Stock
J - Other -350.000 1.852.444 -15,89
2012-05-31 2012-05-31 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
S - Sale -338.500 4.500.619 -7,00 6,55 -2.217.344 29.481.305
2012-05-31 2012-05-30 4 IMI INTERMOLECULAR INC
Stock Option (right to buy)
A - Award 10.000 10.000
2012-05-31 2012-05-30 4 MXL MAXLINEAR INC
Class A Common Stock ($0.0001 par value)
S - Sale -1.640 0 -100,00 4,20 -6.891
2012-05-31 2012-05-30 4 MXL MAXLINEAR INC
Class A Common Stock ($0.0001 par value)
S - Sale -3.235 0 -100,00 4,20 -13.593
2012-05-17 2012-05-15 4 MXL MAXLINEAR INC
Class B Common Stock (convertible into Class A Common Stock)
C - Conversion -1.640 13.258 -11,01
2012-05-17 2012-05-15 4 MXL MAXLINEAR INC
Class B Common Stock (convertible into Class A Common Stock)
C - Conversion -3.235 26.154 -11,01
2012-05-17 2012-05-15 4 MXL MAXLINEAR INC
Class B Common Stock (convertible into Class A Common Stock)
C - Conversion -3.378 27.314 -11,01
2012-05-17 2012-05-15 4 MXL MAXLINEAR INC
Class B Common Stock (convertible into Class A Common Stock)
C - Conversion -350.000 2.829.845 -11,01
2012-05-17 2012-05-15 4 MXL MAXLINEAR INC
Class A Common Stock ($0.0001 par value)
J - Other -3.378 0 -100,00
2012-05-17 2012-05-15 4 MXL MAXLINEAR INC
Class A Common Stock ($0.0001 par value)
J - Other -350.000 0 -100,00
2012-05-17 2012-05-15 4 MXL MAXLINEAR INC
Class A Common Stock ($0.0001 par value)
C - Conversion 1.640 1.640
2012-05-17 2012-05-15 4 MXL MAXLINEAR INC
Class A Common Stock ($0.0001 par value)
C - Conversion 3.235 3.235
2012-05-17 2012-05-15 4 MXL MAXLINEAR INC
Class A Common Stock ($0.0001 par value)
C - Conversion 3.378 3.378
2012-05-17 2012-05-15 4 MXL MAXLINEAR INC
Class A Common Stock ($0.0001 par value)
C - Conversion 350.000 350.000
2012-05-15 2012-05-15 4 MLNX Mellanox Technologies, Ltd.
Ordinary Shares
A - Award 5.000 15.000 50,00
2012-05-15 2012-05-15 4 IMI INTERMOLECULAR INC
Common Stock, $0.001 per share
J - Other -537.600 4.839.119 -10,00
2012-04-25 2012-04-24 4 GWRE Guidewire Software, Inc.
Common Stock
S - Sale -15.860 43.843 -26,56 28,25 -448.045 1.238.565
2012-04-25 2012-04-24 4 GWRE Guidewire Software, Inc.
Common Stock
S - Sale -29.561 81.720 -26,56 28,25 -835.098 2.308.590
2012-04-25 2012-04-24 4 GWRE Guidewire Software, Inc.
Common Stock
S - Sale -23.250 64.270 -26,57 28,25 -656.812 1.815.628
2012-04-25 2012-04-24 4 GWRE Guidewire Software, Inc.
Common Stock
S - Sale -3.155.311 8.722.862 -26,56 28,25 -89.137.536 246.420.852
2012-03-29 2009-10-30 4/A MLNX Mellanox Technologies, Ltd.
Ordinary Shares
S - Sale -53.000 26.633 -66,56 17,47 -925.698 465.172
2012-03-29 2009-10-30 4/A MLNX Mellanox Technologies, Ltd.
Ordinary Shares
M - Exercise 53.000 79.633 199,00 6,65 352.450 529.559
2012-01-30 2012-01-30 4 GWRE Guidewire Software, Inc.
Series C Convertible Preferred Stock
C - Conversion -4.886 0 -100,00
2012-01-30 2012-01-30 4 GWRE Guidewire Software, Inc.
Series C Convertible Preferred Stock
C - Conversion -9.107 0 -100,00
2012-01-30 2012-01-30 4 GWRE Guidewire Software, Inc.
Series C Convertible Preferred Stock
C - Conversion -7.163 0 -100,00
2012-01-30 2012-01-30 4 GWRE Guidewire Software, Inc.
Series C Convertible Preferred Stock
C - Conversion -972.110 0 -100,00
2012-01-30 2012-01-30 4 GWRE Guidewire Software, Inc.
Series B Convertible Preferred Stock
C - Conversion -9.460 0 -100,00
2012-01-30 2012-01-30 4 GWRE Guidewire Software, Inc.
Series B Convertible Preferred Stock
C - Conversion -17.632 0 -100,00
2012-01-30 2012-01-30 4 GWRE Guidewire Software, Inc.
Series B Convertible Preferred Stock
C - Conversion -13.868 0 -100,00
2012-01-30 2012-01-30 4 GWRE Guidewire Software, Inc.
Series B Convertible Preferred Stock
C - Conversion -1.882.117 0 -100,00
2012-01-30 2012-01-30 4 GWRE Guidewire Software, Inc.
Series A Convertible Preferred Stock
C - Conversion -43.981 0 -100,00
2012-01-30 2012-01-30 4 GWRE Guidewire Software, Inc.
Series A Convertible Preferred Stock
C - Conversion -81.976 0 -100,00
2012-01-30 2012-01-30 4 GWRE Guidewire Software, Inc.
Series A Convertible Preferred Stock
C - Conversion -64.475 0 -100,00
2012-01-30 2012-01-30 4 GWRE Guidewire Software, Inc.
Series A Convertible Preferred Stock
C - Conversion -8.750.236 0 -100,00
2012-01-30 2012-01-30 4 GWRE Guidewire Software, Inc.
Common Stock
C - Conversion 58.327 59.703 4.238,88
2012-01-30 2012-01-30 4 GWRE Guidewire Software, Inc.
Common Stock
C - Conversion 108.715 111.281 4.236,75
2012-01-30 2012-01-30 4 GWRE Guidewire Software, Inc.
Common Stock
C - Conversion 85.506 87.520 4.245,58
2012-01-30 2012-01-30 4 GWRE Guidewire Software, Inc.
Common Stock
C - Conversion 11.604.463 11.878.173 4.239,69
2012-01-24 3 GWRE Guidewire Software, Inc.
Common Stock
273.710
2012-01-24 3 GWRE Guidewire Software, Inc.
Common Stock
2.014
2012-01-24 3 GWRE Guidewire Software, Inc.
Common Stock
2.566
2012-01-24 3 GWRE Guidewire Software, Inc.
Common Stock
1.376
2011-05-19 2007-05-11 4/A MLNX Mellanox Technologies, Ltd.
Non Qualified Stock Option (right to buy)
A - Award 11.428 11.428
2007-08-21 3/A MLNX Mellanox Technologies, Ltd.
Ordinary Shares (Common)
39.193
2007-08-21 3/A MLNX Mellanox Technologies, Ltd.
Ordinary Shares (Common)
1.095
2007-08-21 3/A MLNX Mellanox Technologies, Ltd.
Ordinary Shares (Common)
1.221
2007-08-21 3/A MLNX Mellanox Technologies, Ltd.
Ordinary Shares (Common)
632
2007-02-07 3 MLNX Mellanox Technologies, Ltd.
Ordinary Shares (Common)
39.193
2007-02-07 3 MLNX Mellanox Technologies, Ltd.
Ordinary Shares (Common)
1.095
2007-02-07 3 MLNX Mellanox Technologies, Ltd.
Ordinary Shares (Common)
1.221
2007-02-07 3 MLNX Mellanox Technologies, Ltd.
Ordinary Shares (Common)
632
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)